Specify Company / Ticker to Get the Summary
Dividend History ASND
Dividend Analytics ASND
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Ascendis Pharma AS
ASNDAscendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark. Address: Tuborg Boulevard 12, Hellerup, Denmark, 2900
Analytics
WallStreet Target Price
232.18 USDP/E Ratio
–Dividend Yield
–Financials ASND
Results | 2019 | Dynamics |